
Ticadax 60mg Tablet
Marketer
Daxia Healthcare
Salt Composition
Ticagrelor (60mg)
Overview Ticadax 60mg Tablet
CardioGuard 60mg tablets are classified as antiplatelet agents, effectively reducing the risk of dangerous blood clot formation within blood vessels. This action helps prevent strokes and heart attacks in individuals with pre-existing heart conditions. CardioGuard 60mg is also indicated for patients who have recently experienced a heart attack, severe angina, or have undergone cardiac stenting. It significantly lowers the probability of recurrent heart attacks, strokes, or stent-related blood clots. Concomitant use with aspirin, another antiplatelet drug, will typically be prescribed by your physician. CardioGuard 60mg may be administered with or without food, consistently at the same time daily. Continuous use is crucial, even in the absence of symptoms, as discontinuation may heighten the risk of cardiovascular events. The most frequently reported adverse effect is increased bleeding; minor cuts or injuries may bleed longer than usual, though this generally resolves spontaneously. Mild shortness of breath may occur, usually subsiding with continued therapy. Report persistent bleeding, worsening or persistent breathlessness to your doctor immediately. CardioGuard 60mg is contraindicated in patients with active internal bleeding (e.g., stomach ulcers, intracranial hemorrhage) or liver disease. Disclose any such conditions to your physician prior to initiating treatment.
Primary Ingredients of Ticadax 60mg Tablet
There is no text provided to rephrase.
Uses of Ticadax 60mg Tablet
Reducing the risk of cardiovascular events
Major Benefits of Ticadax 60mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Ticadax 60mg Tablet whole; do not alter its form. It can be taken with or without food, though consistency in timing is recommended.
Common Side effects of Ticadax 60mg Tablet:
- Bleeding
- Breathlessness
How to use Ticadax 60mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Ticadax 60mg Tablet whole; avoid chewing, crushing, or breaking it. This medication can be taken with or without food, although consistent timing is recommended.
How Ticadax 60mg Tablet works:
Aggrenox 60mg tablets function as an antiplatelet agent, inhibiting platelet aggregation to reduce the risk of dangerous thrombus formation, thus mitigating the likelihood of stroke or myocardial infarction.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining alcohol and Ticadax 60mg tablets. Seek medical advice before doing so.
PregnancyCONSULT YOUR DOCTOR
The use of Ticadax 60mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
Data on Ticadax 60mg Tablet use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingSAFE
Driving ability is typically unaffected by Ticadax 60mg tablets.
KidneySAFE IF PRESCRIBED
Patients with kidney disease can safely use Ticadax 60mg tablets without requiring a dosage change. Data on Ticadax 60mg tablet use in individuals undergoing renal dialysis is limited.
LiverCAUTION
Patients with liver impairment should use Ticadax 60mg tablets cautiously, potentially requiring dosage modification. Severe hepatic dysfunction contraindicates the use of Ticadax 60mg tablets; physician consultation is advised.
What if you forget to take Ticadax 60mg Tablet :
Should you forget a Ticadax 60mg Tablet dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Ticadax 60mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Triazolopyrimidine derivatives |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Actions | ADP receptor antagonists (P2Y12 inhibitors) |
